Last reviewed · How we verify
NCT05212181
Clinic to Home Robotics-assisted Telerehabilitation for Upper Limb (CHISEL)
trial testing H-Man in Stroke in 12 participants. Completed in 31 December 2022.
10 November 2022
Quick facts
| Lead sponsor | Tan Tock Seng Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 12 |
| Start date | 10 February 2022 |
| Primary completion | 10 November 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- H-Man
Conditions studied
- Stroke — all drugs for Stroke →
Sponsor
Tan Tock Seng Hospital
Who can join
Adults 21 to 90, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Hemiparetic weakness is common after stroke and only a small group of patients achieve useful upper limb function despite best rehabilitation efforts. This is due to the lack of intensive upper limb therapies to drive neuroplasticity either in clinic or at home. In this study, we plan to pilot home-based, robot-aided-therapy using H-man to deliver intensive arm rehabilitation.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Telerehabilitation using a 2-D planar arm rehabilitation robot for hemiparetic stroke: a feasibility study of clinic-to-home exergaming therapy.
Aguirre-Ollinger G, Chua KSG, Ong PL, Kuah CWK, et al · · 2024 · cited 6× · PMID 39593101 · DOI 10.1186/s12984-024-01496-6
Verify or expand the search:
- PubMed search for NCT05212181
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of H-Man
Trials testing the same drug.
- NCT02188628 — Refinement and Clinical Evaluation of the H-Man for Arm Rehabilitation After Stroke · NA · completed
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Tan Tock Seng Hospital trials
Trials by the same sponsor.
- NCT07078240 — Examining Nurses' Trust and Acceptance of FAIR, an AI-powered Falls Risk Recommender · NA · not yet recruiting
- NCT07257341 — Pilot Study of Normative Range of Field of Binocular Single Vision in Adults in Singapore · recruiting
- NCT07151729 — Use of Anodal tDCS to Enhance Upper Limb Recovery in Stroke · NA · recruiting
- NCT07122752 — Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy · active not recruiting
- NCT07255859 — CRYSTALSIGHT Cohort 2.0 · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05212181 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tan Tock Seng Hospital
- Last refreshed: 21 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05212181.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing